REVVITY, INC. (RVTY)
Laboratory Analytical Instruments · Healthcare · $11.3B
Intrinsic Value (Consensus)
$43.59
Current Price
$101.22
Margin of Safety
-56.9%
56.9% Above Intrinsic Value
Value: $44
Price: $101
Valuation Model Estimates
Current Price: $101.22
DCF (Discounted Cash Flow)
$57.86
Graham Number
$55.00
Earnings Power Value
$20.10
Relative Value (P/E)
$41.40
Dividend Discount Model
$0.84
Consensus Value
$43.59
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
48
Profitability
12/25
Strength
22/25
Valuation
7/25
Growth
7/25
Key Financials
- EPS (TTM)
- $2.07
- EPS (Forward)
- $2.11
- Book Value
- $64.95
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 3.3%
- Debt/Equity
- 54%
- Revenue Growth
- 3.7%
- Earnings Growth
- 2.0%
- Dividend Yield
- 0.2%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance